冠状动脉CT血管成像超低剂量对比剂方案的可行性
前瞻性纳入214例冠状动脉CTA患者,分为常规对比剂剂量A组(n=107)和超低剂量B组(n=107),比较CT值、辐射剂量和图像质量,并评估轻度慢性肾脏病患者肾功能变化。B组图像质量与A组相当、满足诊断要求,辐射剂量显著低于A组;轻度CKD患者CTA后肾功能无显著差异。
要点
- 超低剂量对比剂方案冠状动脉CTA图像质量与常规剂量相当,满足诊断要求。
- 超低剂量方案辐射剂量118.70 ± 18.52 mGy·cm,低于常规方案的131.75 ± 20.96 mGy·cm。
- 轻度慢性肾脏病患者冠状动脉CTA后肾功能指标无显著差异。
核心结论
- 建立了冠状动脉CTA超低对比剂方案,图像质量和诊断效能与常规方案相当,辐射剂量显著更低。
- 该新方案可能适用于轻度慢性肾脏病患者。
研究设计与样本
- 前瞻性研究,共纳入214例接受冠状动脉CTA的患者。
- A组(n=107)接受常规对比剂剂量,B组(n=107)接受超低对比剂剂量。
- 测量右冠状动脉、左前降支和左回旋支的CT值并记录辐射剂量,比较两组图像质量。
- 评估慢性肾脏病患者冠状动脉CTA前、后24小时和72小时的肾功能指标及蛋白尿变化。
诊断标准与关键数值
- A组右冠状动脉、左前降支、左回旋支平均CT值分别为412.5 ± 79.2、423.5 ± 73.7、422.0 ± 88.1 HU。
- B组右冠状动脉、左前降支、左回旋支平均CT值分别为275.2 ± 16.2、277.8 ± 16.4、278.9 ± 16.5 HU。
- 超低方案辐射剂量118.70 ± 18.52 mGy·cm,常规冠状动脉CTA为131.75 ± 20.96 mGy·cm。
临床应用与阅片要点
- 超低对比剂剂量方案可用于冠状动脉CTA,图像质量满足诊断要求。
- 该方案可能适用于轻度慢性肾脏病患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the feasibility of an ultra-low volume contrast media (CM) protocol for coronary computed tomography angiography (CTA).
MATERIALS AND METHODS: In total, 214 patients receiving coronary CTA were enrolled prospectively and divided into group A (n=107) receiving a conventional dose of CM and group B (n=107) receiving an ultra-low dose. CT values of the right coronary artery (RCA), left anterior descending artery (LAD), and left circumflex artery (LCX) were measured and radiation doses recorded. The image quality was compared between the groups. Changes in renal function indices and proteinuria before, 24, and 72 hours after coronary CTA among those with chronic kidney disease (CKD) were also assessed.
RESULTS: There were significant differences in CT values and radiation doses between groups A and B. In group A, the average RCA, LAD, and LCX CT values were 412.5 ± 79.2, 423.5 ± 73.7, and 422.0 ± 88.1 HU, respectively. In group B, the average RCA, LAD, and LCX CT values were 275.2 ± 16.2, 277.8 ± 16.4, and 278.9 ± 16.5 HU, respectively. The radiation dose in the ultra-low protocol recipients (118.70 ± 18.52 mGy·cm) was significantly lower than that used in conventional coronary CTA (131.75 ± 20.96 mGy·cm). The image quality of group B was comparable to that of group A, satisfying the diagnostic requirement. In patients with mild CKD, there were no significant differences in renal functions after coronary CTA.
CONCLUSION: An ultra-low CM protocol was established for coronary CTA, providing comparable image quality and diagnostic yields but significantly lower radiation dose compared with a conventional protocol. This new protocol might be applicable to patients with mild CKD.
引用
- Luan, Gao, Sun, et al. Feasibility of an ultra-low dose contrast media protocol for coronary CT angiography. Clin Radiol. 2022. PMID: 35778294. doi:10.1016/j.crad.2022.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。